• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性甲状旁腺功能亢进症患者的总 25-羟维生素 D 水平降低,但计算或测量的游离 25-羟维生素 D 血清水平无差异。

Lower total 25-hydroxyvitamin D but no difference in calculated or measured free 25-hydroxyvitamin D serum levels in patients with primary hyperparathyroidism.

机构信息

Department of Nutritional Sciences, Rutgers University, New Brunswick, NJ, 08901, USA.

Graduate School of Biomedical Science, Rutgers University, Piscataway, NJ, 08854, USA.

出版信息

J Steroid Biochem Mol Biol. 2020 May;199:105616. doi: 10.1016/j.jsbmb.2020.105616. Epub 2020 Feb 3.

DOI:10.1016/j.jsbmb.2020.105616
PMID:32027935
Abstract

To evaluate the measured free 25-hydroxyvitamin D [25(OH)D] levels in patients with hyperparathyroidism (PHPT) and healthy controls. Eighty patients with PHPT(n = 40) and age and BMI matched controls (n = 40) were examined. Serum levels of total or free 25(OH)D, vitamin D binding protein (DBP), intact parathyroid hormone (iPTH) and calcium were measured. There was no significant difference in age (61.2 ± 11.9 vs 60.2 ± 7.0 years) and BMI (30.0 ± 6.1 vs 30.0 ± 2.2 kg/m) between PHPT patients and healthy subjects. Levels of total 25(OH)D were about 20 % lower in PHPT patients (26.4 ± 7.7 ng/mL) compared to controls (31.0 ± 7.8 ng/mL, P < 0.05). There were no significant differences in calculated or measured free 25(OH)D levels between PHPT patients (4.9 ± 1.8 or 4.9 ± 1.6 pg/mL, respectively) and control subjects (5.1 ± 1.2 or 5.3 ± 1.6 pg/mL, respectively). Levels of free 25(OH)D were positively associated with levels of total 25(OH)D (r = 0.28, P < 0.05) but negatively correlated with iPTH and calcium levels (r=-0.22 and -0.23 respectively, P < 0.05). Serum total 25(OH)D levels were lower but the calculated or measured free 25(OH)D levels in patients with PHPT did not differ from healthy subjects. We suggest that total 25(OH)D levels may not reflect true vitamin D nutritional status in patients with PHPT.

摘要

评估甲状旁腺功能亢进症 (PHPT) 患者和健康对照者的游离 25-羟维生素 D [25(OH)D] 实测值。共检查 80 例 PHPT 患者(n = 40)和年龄、BMI 匹配的对照组(n = 40)。测定血清总或游离 25(OH)D、维生素 D 结合蛋白(DBP)、全段甲状旁腺激素(iPTH)和钙水平。PHPT 患者与健康受试者的年龄(61.2 ± 11.9 岁比 60.2 ± 7.0 岁)和 BMI(30.0 ± 6.1 千克/平方米比 30.0 ± 2.2 千克/平方米)无显著差异。PHPT 患者的总 25(OH)D 水平较对照组低约 20%(26.4 ± 7.7 纳克/毫升比 31.0 ± 7.8 纳克/毫升,P < 0.05)。PHPT 患者(4.9 ± 1.8 或 4.9 ± 1.6 皮克/毫升,分别)和对照组(5.1 ± 1.2 或 5.3 ± 1.6 皮克/毫升,分别)的计算或实测游离 25(OH)D 水平无显著差异。游离 25(OH)D 水平与总 25(OH)D 水平呈正相关(r = 0.28,P < 0.05),但与 iPTH 和钙水平呈负相关(r =-0.22 和-0.23,P < 0.05)。PHPT 患者的血清总 25(OH)D 水平较低,但计算或实测游离 25(OH)D 水平与健康受试者无差异。我们认为,PHPT 患者的总 25(OH)D 水平可能不能反映真实的维生素 D 营养状态。

相似文献

1
Lower total 25-hydroxyvitamin D but no difference in calculated or measured free 25-hydroxyvitamin D serum levels in patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者的总 25-羟维生素 D 水平降低,但计算或测量的游离 25-羟维生素 D 血清水平无差异。
J Steroid Biochem Mol Biol. 2020 May;199:105616. doi: 10.1016/j.jsbmb.2020.105616. Epub 2020 Feb 3.
2
FREE AND BIOAVAILABLE 25-HYDROXYVITAMIN D LEVELS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM.原发性甲状旁腺功能亢进患者的游离及生物可利用25-羟维生素D水平
Endocr Pract. 2017 Jan;23(1):66-71. doi: 10.4158/EP161434.OR. Epub 2016 Sep 28.
3
Vitamin D-binding protein levels in female patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进症女性患者的维生素 D 结合蛋白水平。
Endocr Pract. 2013 Jul-Aug;19(4):609-13. doi: 10.4158/EP12371.OR.
4
LOW FREE (BUT NOT TOTAL) 25-HYDROXYVITAMIN D LEVELS IN SUBJECTS WITH NORMOCALCEMIC HYPERPARATHYROIDISM.低游离(而非总)25-羟维生素 D 水平在血钙正常甲状旁腺功能亢进症患者中。
Endocr Pract. 2020 Feb;26(2):174-178. doi: 10.4158/EP-2019-0325. Epub 2019 Sep 26.
5
Total and free vitamin D metabolites in patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者的总维生素 D 代谢物和游离维生素 D 代谢物。
J Endocrinol Invest. 2022 Feb;45(2):301-307. doi: 10.1007/s40618-021-01633-1. Epub 2021 Jul 19.
6
25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy.原发性甲状旁腺功能亢进患者甲状旁腺切除术前及术后的25-羟基维生素D和维生素D结合蛋白水平
Front Endocrinol (Lausanne). 2019 Mar 27;10:171. doi: 10.3389/fendo.2019.00171. eCollection 2019.
7
Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.饮食维生素 D 摄入与老年人的 25-羟维生素 D3 或甲状旁腺激素无关,而钙磷比值影响甲状旁腺激素。
Nutr Res. 2013 Aug;33(8):661-7. doi: 10.1016/j.nutres.2013.05.011. Epub 2013 Jun 28.
8
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.家族性低钙血症性高钙血症和原发性甲状旁腺功能亢进症中的血浆25-羟维生素D、1,25-二羟维生素D和甲状旁腺激素
Eur J Endocrinol. 2008 Dec;159(6):719-27. doi: 10.1530/EJE-08-0440. Epub 2008 Sep 11.
9
Urinary calcium excretion in primary hyperparathyroidism: relationship to 25-hydroxyvitamin d status.原发性甲状旁腺功能亢进症患者的尿钙排泄:与25-羟基维生素D状态的关系。
Endocr Pract. 2005 Jan-Feb;11(1):37-42. doi: 10.4158/EP.11.1.37.
10
Vitamin D status in primary hyperparathyroidism: effect of genetic background.原发性甲状旁腺功能亢进症中的维生素D状态:遗传背景的影响
Endocrine. 2017 Jan;55(1):266-272. doi: 10.1007/s12020-016-0974-x. Epub 2016 May 6.

引用本文的文献

1
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes.再探甲状旁腺疾病中的骨:来自流行病学、手术及新药疗效的证据
Endocr Rev. 2025 Jul 15;46(4):576-620. doi: 10.1210/endrev/bnaf010.
2
Total and free vitamin D metabolites in patients with primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者的总维生素 D 代谢物和游离维生素 D 代谢物。
J Endocrinol Invest. 2022 Feb;45(2):301-307. doi: 10.1007/s40618-021-01633-1. Epub 2021 Jul 19.